Suppression of cytophilic antibody ('arming' factor) in the sera of patients with prostatic cancer by human seminal plasma

R. A. Bhatti; R. J. Ablin; S. Zamora; E. Totonchi; I. M. Bush; P. D. Guinan

doi:10.1007/BF01952320

Suppression of cytophilic antibody ('arming' factor) in the sera of patients with prostatic cancer by human seminal plasma

R. A. Bhatti, R. J. Ablin, S. Zamora, E. Totonchi, I. M. Bush, P. D. Guinan

Research output: Contribution to journal › Article › peer-review

Abstract

The 'arming' of normal peripheral blood leukocytes (PBL) by cytophilic antibody in the sera of prostatic cancer patients is suppressed by pretreatment of PBL with normal human seminal plasma (HuSP1). Suppression of cytophilic antibody by HuSP1 extends the spectrum of immunologic reactions on which SP1 has an immunosuppressive effect and may provide further insight into the possible role of SP1 in the natural history of prostatic cancer.

Original language	English (US)
Pages (from-to)	349-350
Number of pages	2
Journal	Experientia
Volume	36
Issue number	3
DOIs	https://doi.org/10.1007/BF01952320
State	Published - Mar 1980
Externally published	Yes

ASJC Scopus subject areas

General Biochemistry, Genetics and Molecular Biology

Access to Document

10.1007/BF01952320

Cite this

@article{c7e82846303a4087982f71fbb254132a,

title = "Suppression of cytophilic antibody ('arming' factor) in the sera of patients with prostatic cancer by human seminal plasma",

abstract = "The 'arming' of normal peripheral blood leukocytes (PBL) by cytophilic antibody in the sera of prostatic cancer patients is suppressed by pretreatment of PBL with normal human seminal plasma (HuSP1). Suppression of cytophilic antibody by HuSP1 extends the spectrum of immunologic reactions on which SP1 has an immunosuppressive effect and may provide further insight into the possible role of SP1 in the natural history of prostatic cancer.",

author = "Bhatti, {R. A.} and Ablin, {R. J.} and S. Zamora and E. Totonchi and Bush, {I. M.} and Guinan, {P. D.}",

year = "1980",

month = mar,

doi = "10.1007/BF01952320",

language = "English (US)",

volume = "36",

pages = "349--350",

journal = "Experientia",

issn = "0014-4754",

publisher = "Springer Science and Business Media Deutschland GmbH",

number = "3",

}

TY - JOUR

T1 - Suppression of cytophilic antibody ('arming' factor) in the sera of patients with prostatic cancer by human seminal plasma

AU - Bhatti, R. A.

AU - Ablin, R. J.

AU - Zamora, S.

AU - Totonchi, E.

AU - Bush, I. M.

AU - Guinan, P. D.

PY - 1980/3

Y1 - 1980/3

N2 - The 'arming' of normal peripheral blood leukocytes (PBL) by cytophilic antibody in the sera of prostatic cancer patients is suppressed by pretreatment of PBL with normal human seminal plasma (HuSP1). Suppression of cytophilic antibody by HuSP1 extends the spectrum of immunologic reactions on which SP1 has an immunosuppressive effect and may provide further insight into the possible role of SP1 in the natural history of prostatic cancer.

AB - The 'arming' of normal peripheral blood leukocytes (PBL) by cytophilic antibody in the sera of prostatic cancer patients is suppressed by pretreatment of PBL with normal human seminal plasma (HuSP1). Suppression of cytophilic antibody by HuSP1 extends the spectrum of immunologic reactions on which SP1 has an immunosuppressive effect and may provide further insight into the possible role of SP1 in the natural history of prostatic cancer.

UR - http://www.scopus.com/inward/record.url?scp=0018898584&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0018898584&partnerID=8YFLogxK

U2 - 10.1007/BF01952320

DO - 10.1007/BF01952320

M3 - Article

C2 - 7371799

AN - SCOPUS:0018898584

SN - 0014-4754

VL - 36

SP - 349

EP - 350

JO - Experientia

JF - Experientia

IS - 3

ER -

Suppression of cytophilic antibody ('arming' factor) in the sera of patients with prostatic cancer by human seminal plasma

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this